High dose granulocyte substitution after bone marrow transplantation in a case of aplastic anaemia in childhood.
A bone marrow transplantation (BMT) was successfully carried out in a seven-year-old boy with aplastic anaemia. An HLA and MLC-identical brother served as donor. During the first 16 days after BMT between 0.55 and 7.11X10(10) granulocytes were transfused 14 times (an average of 4.03X10(10) per transfusion). The maximum increment in the peripheral blood after transfusion was over 4000 granulocytes per microliter. The course of local infections was taken as parameter for determining the clinical effectiveness of the granulocyte transfusion. Under the substitution therapy the necrotic ulcer of a fingertip and the mucous membrane ulcers in the oral cavity subsided. The presence of transfused granulocytes in the oral cavity ("orogranulocytes") could be established. There was a statistically significant relationship between the number of granulocytes in the peripheral blood and the number of orogranulocytes. It could be demonstrated that in children a temporary normalisation of the number of granulocytes in the peripheral blood can be attained by means of granulocyte substitution and that the transfused granulocytes are clinically effective.
D000741:Anemia, Aplastic / Q000628:therapy*; D000906:Antibodies / Q000032:analysis; D001803:Blood Transfusion; D016026:Bone Marrow Transplantation; D002648:Child; D006098:Granulocytes / Q000637:transplantation*; D006650:Histocompatibility Testing; D006801:Humans; D007937:Leukapheresis; D007962:Leukocytes / Q000276:immunology; D008297:Male; D014184:Transplantation, Homologous
D000906:Antibodies